R-CHOP chemotherapy

DRUG2 trials

Sponsors

University Hospital Muenster, University Health Network, Toronto

Conditions

Diffuse Large B Cell LymphomaMantle Cell Lymphoma

Phase 2

Copanlisib in Combination With Rituximab and CHOP Chemotherapy in Patients With Previously Untreated DLBCL

CompletedNCT04263584

University Hospital MuensterDiffuse Large B Cell Lymphoma

Start: 2020-06-19End: 2025-05-03Updated: 2026-07-30

Acalabrutinib With R-CHOP in Previously Untreated Mantle Cell Lymphoma

Active, not recruitingNCT04566887

University Health Network, TorontoMantle Cell Lymphoma

Start: 2021-03-01End: 2032-04-30Target: 105Updated: 2026-06-12

Related Papers

Rituximab Combined with Chemotherapy and Acalabrutinib Prior to Autologous Stem Cell Transplantation in Mantle Cell Lymphoma: The Rectangle Trial

Blood2023-11-021 citations

Rituximab combined with chemotherapy and acalabrutinib prior to autologous stem cell transplantation in mantle cell lymphoma: The Rectangle Trial

Hematological Oncology2023-06-011 citations

A PHASE II STUDY OF ACALABRUTINIB IN COMBINATION WITH R‐CHOP CHEMOTHERAPY PRIOR TO AUTOLOGOUS STEM CELL TRANSPLANTATION IN PREVIOUSLY UNTREATED MANTLE CELL LYMPHOMA

Hematological Oncology2021-06-01